Shilpa Medicare has received USFDA final approval for its abbreviated new drug application.

Health regulators raised a red flag over a defect in the sealing of Docetaxel injection vials- a drug used for treating breast cancer.

Docetaxel injection USP 20 mg/mL and 80 mg/4 mL are available as a single dose, one vial formulation that does not require a prior dilution.

Dabur Pharma has entered into an agreement with Government Pharmaceutical Organization of Thailand for the generic of one of its key anti-c...